Showing results (2361-2370 of 2,375) with videos related to

Sort By:
Pageof 238
Biomarker Research|October 9, 2025
Analysis of ultrastructural defects in sperm by transmission electron microscopy in asthenozoospermia patients: a study from multiple centers across ChinaMo-Qi Lv, Hai-Xu Wang, Hou-Yang Chen, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|July 26, 2007
[Multi-center phase II clinical trial of humanized anti-epidermal factor receptor monoclonal antibody h-R3 combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma]Xiao-dong Huang, Jun-lin Yi, Li Gao, et al.
Alimentary Pharmacology & Therapeutics|March 31, 2026
Camrelizumab and Apatinib With or Without Transarterial Chemoembolisation as First-Line Treatment for Advanced Hepatocellular Carcinoma (CHANCE2311)Rong Ding, Jin-Feng Bai, Zhi-Cheng Jin, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 8, 2020
A Middle Eocene lowland humid subtropical "Shangri-La" ecosystem in central TibetTao Su, Robert A Spicer, Fei-Xiang Wu, et al.
Nature Communications|October 29, 2014
The complex jujube genome provides insights into fruit tree biologyMeng-Jun Liu, Jin Zhao, Qing-Le Cai, et al.
Plos One|June 9, 2016
Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World DataGuo-Feng Chen, Lai Wei, Jing Chen, et al.
Cell|July 6, 2024
Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumorsYikai Luo, Yu Xia, Dan Liu, et al.
Frontiers in Medicine|October 4, 2021
Chinese Medicine Formula Huashibaidu Granule Early Treatment for Mild COVID-19 Patients: An Unblinded, Cluster-Randomized Clinical TrialChen Zhao, Li Li, Wei Yang, et al.
Hepatology (Baltimore, Md.)|November 10, 2025
Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus immunotherapy and targeted therapy in HCC (CHANCE2204)Zhi-Cheng Jin, Jingwei Wei, Yu-Dong Xiao, et al.
Breast Cancer Research and Treatment|December 13, 2017
Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III studyJie Xie, Jun Cao, Jing-Fen Wang, et al.
Pageof 238